Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
08/2003
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158427 Using Wittig or Wittig-Horner reaction; use in selective synthesis of various C40 carotenoids
08/21/2003US20030158426 From 4-hydroxy-6-X-substituted-methyl-tetrahydropyran-2-one compounds, where X is a leaving group, with the aid of an acetalization agent, in the presence of an acid catalyst
08/21/2003US20030158412 A pentanoic amide derivatives as chemical intermediates for antitumor agents
08/21/2003US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
08/20/2003EP1077212B1 Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives
08/20/2003CN1437647A Supertwisted nematic liquid crystal displays, liquid crystal compositions and compounds
08/20/2003CN1437581A Glucagon antagonists/inverse agonists
08/20/2003CN1437575A Aminomethyl-phenyl-cyclohexanone derivatives
08/20/2003CN1118449C Liquid crystal compound, liquid crystal containing liquid crystal compound and liquid crystal display device using the same composition
08/19/2003US6608200 Saponification and amidation of ethyl-2,3-dihydrobenzo(1,4)-dioxin-2-carboxylate with piperazine; purification
08/19/2003US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
08/19/2003US6608061 Bisaryl compound and medicament for cancer treatment comprising the same
08/19/2003CA2043733C Aromatic compounds
08/14/2003WO2003024955A3 Small molecule inhibitors of caspases
08/14/2003US20030153706 5- or 6-membered ring acetal structure is connected to a norbornene structure through a linker represented by -(CH2)m-m=1 to 8 used as monomer; polymer is sensitive to high energy radiation excellent resolution, and etching resistance
08/14/2003US20030153597 Therapeutic treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease, nervous system disorders and cardiovascular disorders
08/13/2003EP1334719A2 Pentafluorobenzenesulfonamides and analogs
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/12/2003US6605747 Reacting the starting material, an alpha , alpha -difluorocyclohexylidene derivative with a halogen to produce an intermediate, reacting the intermediate with a phenol compound in presence of a base
08/12/2003US6605632 Affinity for melatonin receptors
08/07/2003WO2003064408A1 “process for the preparation of ethyl 2, 3-dihydrobenzo[1,4]dioxin-2-carboxylate”
08/07/2003US20030149281 Protected 3,-5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production
08/07/2003US20030149234 Orthothioloesters or carboxyester thiols for production/ ligation of (poly)peptides
08/07/2003DE10158907C1 Riechstoffe auf Basis von Cyclohexyl- und Cyclohexenyl-propyl-1,3-dioxanen, Verfahren zu deren Herstellung und diese enthaltende Riechstoffkompositionen, sowie Cyclohexyl- und Cyclohexenyl-propyl-1,3-dioxane als solche Fragrances based on cyclohexyl and cyclohexenyl-propyl-1,3-dioxanes, process for their production and fragrance compositions comprising them, as well as cyclohexyl and cyclohexenyl-propyl-1,3-dioxanes as such
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003CN1117055C Pesticide compounds, compositions and process for preparation thereof
08/05/2003US6602903 Substituted heterocyclic compounds
08/05/2003CA2275827C Method for treating glaucoma
08/05/2003CA2202643C Acetal derivatives of resole compounds
07/2003
07/31/2003US20030144533 Synthetic intermediate for epothilone derivative and production method thereof
07/31/2003US20030144532 Method of manufacture of 1,3-oxathiolane nucleosides
07/31/2003US20030144523 Epothilone derivatives, method for producing same and their pharmaceutical use
07/31/2003US20030144292 Protease inhibitors such as N-((4'-Methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl-N-methyl-amino)-(4 -hydroxycyclohexan-1-yl)-acetic acid for prophylaxis of neurodegenerative diseases, vision defects, skin disorders or as antiinflammatory agents
07/30/2003EP0928791B1 Process for producing 1,4-benzodioxane derivatives
07/30/2003CN1116271C Method of producing 2-substituted-3,4-fused heterocycle benzoic acid
07/29/2003US6599590 Unsaturated fluorine compound
07/24/2003WO2003059901A1 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivates
07/24/2003WO2003059874A2 Aromatic thioether liver x-receptor modulators
07/24/2003US20030139612 A nucleating agents for plastic, especially improving the optical properties; food or cosmetic containers and packagings, gelling agents for preparation of antiperspirant gel sticks
07/24/2003US20030139449 Anxiolytic agents; psychological disorders; cognition activators
07/24/2003US20030136659 Applying electromagnetic waves; heating; decomposition
07/24/2003CA2471311A1 Aromatic thioether liver x-receptor modulators
07/23/2003EP1328522A2 Estrogen receptor modulators
07/23/2003CN1432006A Method for purification of cyclic ester
07/22/2003US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
07/22/2003US6596759 Medicament for treatment of irritable bowel syndrome
07/22/2003US6596722 Serotonin reuptake inhibitors/HT3 receptor antagonists useful for treatment of depression, psychosis, anxiety disorders, panic disorder, obsessive compulsive disorder, and eating disorders
07/17/2003WO2003057254A1 Preventives/remedies for urinary disturbance
07/17/2003US20030134900 Process for the preparation of dihydroxy esters and derivatives thereof
07/17/2003CA2471760A1 Preventives/remedies for urinary disturbance
07/16/2003CN1429803A Method for preparing polyenoid dialdehyde monoaldehyde acetal
07/16/2003CN1114601C Spiro lactone compounds and synthesizing method therefor
07/16/2003CN1114596C Biphenyl derivatives
07/15/2003US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/10/2003WO2003055873A1 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
07/10/2003US20030130519 Reacting 6-aminocarbonylmethyl-4H-2,3-dioxin-4-one compounds with water or an alcohol to form 3-oxopentanedicarboxylic acid monoamides or their monoesters which are useful as medicinals, agrochemicals as raw materials for polyamides.
07/10/2003US20030130512 Process for the production of purine derivatives and intermediates therefor
07/10/2003US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect
07/10/2003US20030130164 Cosmetics, cleaning compounds
07/10/2003US20030127629 Positive dielectric anisotropy
07/10/2003CA2467337A1 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
07/09/2003EP1325919A1 Process for the preparation of polyendialdehydemonoacetals
07/09/2003EP0966490B1 Catalyst compositions for the polymerization of olefins
07/09/2003CN1429198A Novel phenyl-proparylether derivatives
07/08/2003US6589914 Dihalopropene compounds, insecticidal/acaridcidal agents containing same, and intermediates for their production
07/03/2003WO2003053952A1 Method of making trimethylene carbonate
07/03/2003WO2003053951A1 Method of making trimethylene carbonate
07/03/2003WO2003053950A1 New process for the preparation of optically active 2-[6-(substituted alkyl)-1,3-dioxan-4-yl]acetic acid derivatives
07/03/2003WO2003053949A1 C1-c6 fragments of epothilones and method for producing such fragments and the derivatives thereof
07/03/2003CA2471094A1 Method of making trimethylene carbonate
07/03/2003CA2470951A1 Method of making trimethylene carbonate
07/02/2003EP1323717A1 Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP1322587A1 Method for producing ketocarboxylic acid derivatives
07/02/2003EP1322403A1 The plasma assisted catalytic treatment of gases
07/02/2003EP1322315A1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid
07/02/2003CN1427818A Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use
07/01/2003US6586465 Esters
06/2003
06/26/2003WO2003051824A1 α-CYANOACRYLATES
06/26/2003US20030120090 Reacting vapor phase 1,3-propanediol and phosgene gas; condensation; solidification; catalyst-free
06/26/2003US20030119851 In the treatment or prevention of psychotic disorders such as schizophrenia psychotic depression, mania and other central nervous system diseases
06/26/2003US20030118933 Norbornene-based copolymer for photoresist, preparation method thereof, and photoresist composition comprising the same
06/26/2003CA2469716A1 .alpha.-cyanoacrylates
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003CN1426384A Method for producing ketal and/or acetal
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003US20030114710 Optical information recording medium and novel immonium compound
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114441 Heterocyclic anti-epileptogenic agents and methods of use thereof
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318974A2 Resorcinol derivatives
06/17/2003US6580001 Method of making trimethylene carbonate
06/17/2003US6579981 Treating herpes virus
06/17/2003US6579823 Group 8-10 metal complex comprising a bidentate or variable denticity ligand; polymerization of olefins
06/12/2003WO2003048117A2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003US20030109722 Method for purification of cyclic ester
06/12/2003US20030109571 Thromboxane ligands without blood clotting side effects
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 103